Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2024 Jun;31(6):e16260.
doi: 10.1111/ene.16260. Epub 2024 Feb 26.

Biomarkers of neurodegeneration in isolated and antidepressant-related rapid eye movement sleep behavior disorder

Affiliations
Observational Study

Biomarkers of neurodegeneration in isolated and antidepressant-related rapid eye movement sleep behavior disorder

Francesco Biscarini et al. Eur J Neurol. 2024 Jun.

Abstract

Background and purpose: This study compared the features of isolated rapid eye movement (REM) sleep behavior disorder (iRBD) and antidepressant-related REM sleep behaviour disorder (RBD) with the aim of highlighting markers that might distinguish the two entities.

Methods: The observational cohort study included RBD patients with and without antidepressant use (antiD+ and antiD- patients, respectively), without cognitive impairment and parkinsonism. Clinical features of RBD, subtle motor and non-motor symptoms of parkinsonism, sleep architecture, REM atonia index, dopamine transporter-single photon emission computed tomography (DAT-SPECT) and skin biopsies for the intraneuronal alpha-synuclein (α-syn), were evaluated in the baseline work-up.

Results: Thirty-nine patients, 10 antiD+ and 29 antiD-, were included. AntiD+ patients (more frequently female) reported more psychiatric symptoms, less violent dream enactment, and less frequent hyposmia. Dermal α-syn was detected in 93.1% of antiD- versus 30% of antiD+ patients (p = 0.00024). No differences appeared in other motor and non-motor symptoms, Movement Disorder Society-Unified Parkinson's Disease Rating Scale part III score, DAT-SPECT, or polysomnographic features.

Conclusions: Patients with antidepressant-related RBD have clinical and neuropathological features suggesting a lower risk of evolution than those with iRBD.

Keywords: alpha‐synuclein; antidepressant‐related REM sleep behavior disorder; skin biopsy.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no conflicts of interest relevant to this work.

References

    1. Postuma RB, Iranzo A, Hu M, et al. Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study. Brain. 2019;142(3):744‐759. doi:10.1093/brain/awz030 - DOI - PMC - PubMed
    1. Lam SP, Zhang J, Li SX, Wing YK. RBD, antidepressant medications, and psychiatric disorders. Rapid‐Eye‐Move Sleep Behav Disord. 2018;18:123‐134. doi:10.1007/978-3-319-90152-7_10 - DOI
    1. Postuma RB, Gagnon JF, Tuineaig M, et al. Antidepressants and REM sleep behavior disorder: isolated side effect or neurodegenerative signal? Sleep. 2013;36(11):1579‐1585. doi:10.5665/sleep.3102 - DOI - PMC - PubMed
    1. American Academy of Sleep Medicine . International Classification of Sleep Disorders. American Academy of Sleep Medicine; 2014. doi:10.1007/978-1-4939-6578-6_27 - DOI
    1. Litvan I, Goldman JG, Tröster AI, et al. Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society task force guidelines. Mov Disord. 2012;27(3):349‐356. doi:10.1002/MDS.24893 - DOI - PMC - PubMed

Publication types

Grants and funding

LinkOut - more resources